Servier, run by a nonprofit group, continues to make money with its IDH-mutant glioma treatment…

New research reveals that attention-deficit/hyperactivity disorder actually consists of at least two distinct brain structural…

Kyowa Kirin has decided to halt all clinical development of its OX40 drug following the…

Almost a century ago, astronomer Edwin Hubble discovered that nearly all galaxies are moving away…

PFAS, toxic “forever chemicals” linked to cancer and other serious health problems, were detected in…

The design of modern research and development labs may need to be rethought. Artificial intelligence…

Outstanding trial results for the combination of Tekvayli and Darzalex Faspro in previously treated relapsed…

Recent research published in current psychology This provides evidence that employees who believe they are…

The Buck Institute on Aging today announced the launch of Healthspan Horizons. This is a…

Get the health information and medications you need every weekday with STAT’s free newsletter Morning…